HighTower Advisors’s Antares Pharma, Inc. ATRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-21,035
| Closed | -$86K | – | 3662 |
|
|
2022
Q1 | $86K | Sell |
21,035
-1,501
| -7% | -$5.45K | ﹤0.01% | 3016 |
|
|
2021
Q4 | $80K | Sell |
22,536
-900
| -4% | -$3.15K | ﹤0.01% | 2963 |
|
|
2021
Q3 | $85K | Buy |
23,436
+500
| +2% | +$2.02K | ﹤0.01% | 2864 |
|
|
2021
Q2 | $99K | Sell |
22,936
-2,485
| -10% | -$10.1K | ﹤0.01% | 2815 |
|
|
2021
Q1 | $104K | Sell |
25,421
-400
| -2% | -$1.73K | ﹤0.01% | 2752 |
|
|
2020
Q4 | $103K | Buy |
25,821
+100
| +0.4% | +$324 | ﹤0.01% | 2347 |
|
|
2020
Q3 | $70K | Sell |
25,721
-500
| -2% | -$1.38K | ﹤0.01% | 2276 |
|
|
2020
Q2 | $72K | Buy |
26,221
+4,485
| +21% | +$12.5K | ﹤0.01% | 2170 |
|
|
2020
Q1 | $53K | Buy |
+21,736
| New | +$73.9K | ﹤0.01% | 2005 |
|
|
2019
Q4 | – | Sell |
-27,236
| Closed | -$92K | – | 2592 |
|
|
2019
Q3 | $92K | Buy |
27,236
+500
| +2% | +$1.65K | ﹤0.01% | 2175 |
|
|
2019
Q2 | $88K | Sell |
26,736
-2,499
| -9% | -$7.23K | ﹤0.01% | 2175 |
|
|
2019
Q1 | $89K | Hold |
29,235
| – | – | ﹤0.01% | 2081 |
|
|
2018
Q4 | $81K | Buy |
29,235
+500
| +2% | +$1.65K | ﹤0.01% | 1989 |
|
|
2018
Q3 | $97K | Buy |
28,735
+15,135
| +111% | +$46.7K | ﹤0.01% | 2062 |
|
|
2018
Q2 | $36K | Hold |
13,600
| – | – | ﹤0.01% | 2086 |
|
|
2018
Q1 | $29K | Hold |
13,600
| – | – | ﹤0.01% | 2049 |
|
|
2017
Q4 | $26K | Buy |
13,600
+500
| +4% | +$1.09K | ﹤0.01% | 2144 |
|
|
2017
Q3 | $44K | Buy |
13,100
+500
| +4% | +$1.54K | ﹤0.01% | 2094 |
|
|
2017
Q2 | $42K | Buy |
12,600
+1,500
| +14% | +$4.25K | ﹤0.01% | 2043 |
|
|
2017
Q1 | $33K | Hold |
11,100
| – | – | ﹤0.01% | 1945 |
|
|
2016
Q4 | $25K | Hold |
11,100
| – | – | ﹤0.01% | 1855 |
|
|
2016
Q3 | $18K | Sell |
11,100
-300
| -3% | -$368 | ﹤0.01% | 1823 |
|
|
2016
Q2 | $11K | Hold |
11,400
| – | – | ﹤0.01% | 1716 |
|
|
2016
Q1 | $8K | Hold |
11,400
| – | – | ﹤0.01% | 2050 |
|
|
2015
Q4 | $12K | Buy |
+11,400
| New | +$15.9K | ﹤0.01% | 1981 |
|
|
2013
Q4 | – | Sell |
-26,410
| Closed | -$272K | – | 1624 |
|
|
2013
Q3 | $272K | Buy |
+26,410
| New | +$115K | 0.01% | 1058 |
|
Other funds holding ATRS
HighTower Advisors's ATRS Position: Q2 2022 in Review
HighTower Advisors sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 21,035 shares — an estimated $86K sold.
HighTower Advisors first reported a position in ATRS in Q3 2013 and held it in 26 quarters. The position peaked at $272K in Q3 2013. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.
- HighTower Advisors reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
- HighTower Advisors sold 21,035 Antares Pharma, Inc. shares in Q2 2022, an estimated $86K.
- HighTower Advisors first reported a position in Antares Pharma, Inc. in Q3 2013 and held it in 26 quarters.
- HighTower Advisors's Antares Pharma, Inc. position peaked at $272K in Q3 2013.
- 1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.
Based on HighTower Advisors's 13F filing for Q2 2022, filed 10 Aug 2022.